Authors
Loading...
Analysis reveals DNMT3A and mitochondrial metabolism drive resistance to ibrutinib in mantle cell lymphoma, suggesting metformin may enhance treatment efficacy.
Lixin Rui (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: